- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 405/14 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Patent holdings for IPC class C07D 405/14
Total number of patents in this class: 11851
10-year publication summary
|
742
|
778
|
890
|
922
|
932
|
944
|
1120
|
1026
|
836
|
498
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| LG Chem, Ltd. | 17921 |
301 |
| Bristol-myers Squibb Company | 4729 |
214 |
| Merck Patent GmbH | 5725 |
210 |
| Boehringer Ingelheim International GmbH | 4493 |
189 |
| Novartis AG | 10263 |
169 |
| LT Materials Co., Ltd. | 444 |
154 |
| Gilead Sciences, Inc. | 2220 |
149 |
| Vertex Pharmaceuticals Incorporated | 1584 |
144 |
| Takeda Pharmaceutical Company Limited | 2715 |
139 |
| Janssen Pharmaceutica N.V. | 3171 |
138 |
| Merck Sharp & Dohme LLC | 3735 |
138 |
| Pfizer Inc. | 3384 |
136 |
| F. Hoffmann-La Roche AG | 7836 |
121 |
| Idemitsu Kosan Co., Ltd. | 4234 |
118 |
| Genentech, Inc. | 4099 |
104 |
| Samsung SDI Co., Ltd. | 10556 |
101 |
| Samsung Display Co., Ltd. | 38570 |
89 |
| Vanderbilt University | 2019 |
79 |
| Hoffmann-La Roche Inc. | 3783 |
78 |
| Amgen Inc. | 4425 |
74 |
| Other owners | 9006 |